Kaveri Pohlman
Stock Analyst at Clear Street
(2.96)
# 1,345
Out of 5,161 analysts
32
Total ratings
40.62%
Success rate
2.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $45 → $70 | $17.84 | +292.38% | 1 | Mar 11, 2026 | |
| ERAS Erasca | Maintains: Buy | $11 → $20 | $15.50 | +29.03% | 1 | Mar 6, 2026 | |
| JANX Janux Therapeutics | Downgrades: Hold | $32 → $12 | $14.08 | -14.77% | 3 | Jan 20, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $12 | $2.00 | +500.00% | 1 | Dec 30, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $61 → $99 | $58.20 | +70.10% | 1 | Dec 9, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $200 | $139.69 | +43.17% | 1 | Dec 5, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $14.02 | +78.32% | 1 | Nov 25, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $11 → $21 | $11.94 | +75.88% | 1 | Nov 14, 2025 | |
| ZURA Zura Bio | Initiates: Buy | $18 | $6.99 | +157.51% | 1 | Nov 13, 2025 | |
| SGMT Sagimet Biosciences | Initiates: Buy | $29 | $5.74 | +405.23% | 1 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $34.41 | +33.68% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $24.61 | +30.03% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.34 | - | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $47 | $27.38 | +71.66% | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $30 | $14.31 | +109.64% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $38 | $12.04 | +215.61% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $4.59 | +8.93% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.56 | +412.82% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $41.75 | -35.33% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.42 | +186.65% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $5.88 | +104.08% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $4.88 | +63.93% | 2 | Jul 7, 2022 |
MoonLake Immunotherapeutics
Mar 11, 2026
Maintains: Buy
Price Target: $45 → $70
Current: $17.84
Upside: +292.38%
Erasca
Mar 6, 2026
Maintains: Buy
Price Target: $11 → $20
Current: $15.50
Upside: +29.03%
Janux Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $32 → $12
Current: $14.08
Upside: -14.77%
Palisade Bio
Dec 30, 2025
Initiates: Buy
Price Target: $12
Current: $2.00
Upside: +500.00%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $61 → $99
Current: $58.20
Upside: +70.10%
Palvella Therapeutics
Dec 5, 2025
Initiates: Buy
Price Target: $200
Current: $139.69
Upside: +43.17%
Jade Biosciences
Nov 25, 2025
Initiates: Buy
Price Target: $25
Current: $14.02
Upside: +78.32%
Trevi Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $11 → $21
Current: $11.94
Upside: +75.88%
Zura Bio
Nov 13, 2025
Initiates: Buy
Price Target: $18
Current: $6.99
Upside: +157.51%
Sagimet Biosciences
Oct 22, 2025
Initiates: Buy
Price Target: $29
Current: $5.74
Upside: +405.23%
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $34.41
Upside: +33.68%
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $24.61
Upside: +30.03%
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.34
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $27.38
Upside: +71.66%
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $14.31
Upside: +109.64%
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $12.04
Upside: +215.61%
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $4.59
Upside: +8.93%
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.56
Upside: +412.82%
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $41.75
Upside: -35.33%
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $24.42
Upside: +186.65%
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $5.88
Upside: +104.08%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $4.88
Upside: +63.93%